121 related articles for article (PubMed ID: 38058200)
1. CASZ1 upregulates PI3K-AKT-mTOR signaling and promotes T-cell acute lymphoblastic leukemia.
Cardoso BA; Duque M; Gírio A; Fragoso R; Oliveira ML; Allen JR; Martins LR; Correia NC; Silveira AB; Veloso A; Kimura S; Demoen L; Matthijssens F; Jeha S; Cheng C; Pui CH; Grosso AR; Neto JL; De Almeida SF; Van Vlieberghe P; Mullighan CG; Yunes JA; Langenau DM; Pflumio F; Barata JT
Haematologica; 2023 Dec; ():. PubMed ID: 38058200
[TBL] [Abstract][Full Text] [Related]
2. CASZ1b, the short isoform of CASZ1 gene, coexpresses with CASZ1a during neurogenesis and suppresses neuroblastoma cell growth.
Liu Z; Naranjo A; Thiele CJ
PLoS One; 2011 Apr; 6(4):e18557. PubMed ID: 21490919
[TBL] [Abstract][Full Text] [Related]
3. Zinc finger transcription factor CASZ1 interacts with histones, DNA repair proteins and recruits NuRD complex to regulate gene transcription.
Liu Z; Lam N; Thiele CJ
Oncotarget; 2015 Sep; 6(29):27628-40. PubMed ID: 26296975
[TBL] [Abstract][Full Text] [Related]
4. Characterization of critical domains within the tumor suppressor CASZ1 required for transcriptional regulation and growth suppression.
Virden RA; Thiele CJ; Liu Z
Mol Cell Biol; 2012 Apr; 32(8):1518-28. PubMed ID: 22331471
[TBL] [Abstract][Full Text] [Related]
5. CASZ1 promotes migration, invasion, and metastasis of lung cancer cells by controlling expression of ITGAV.
Taheri Baghmisheh S; Wu YY; Wu JE; Hsu KF; Chen YL; Hong TM
Am J Cancer Res; 2023; 13(1):176-189. PubMed ID: 36777515
[TBL] [Abstract][Full Text] [Related]
6. New insights into Notch1 regulation of the PI3K-AKT-mTOR1 signaling axis: targeted therapy of γ-secretase inhibitor resistant T-cell acute lymphoblastic leukemia.
Hales EC; Taub JW; Matherly LH
Cell Signal; 2014 Jan; 26(1):149-61. PubMed ID: 24140475
[TBL] [Abstract][Full Text] [Related]
7. TAL1 cooperates with PI3K/AKT pathway activation in T-cell acute lymphoblastic leukemia.
Thielemans N; Demeyer S; Mentens N; Gielen O; Provost S; Cools J
Haematologica; 2022 Oct; 107(10):2304-2317. PubMed ID: 35354248
[TBL] [Abstract][Full Text] [Related]
8. CASZ1b is a novel transcriptional corepressor of mineralocorticoid receptor.
Yokota K; Shibata H; Kurihara I; Kobayashi S; Murai-Takeda A; Itoh H
Hypertens Res; 2021 Apr; 44(4):407-416. PubMed ID: 33077905
[TBL] [Abstract][Full Text] [Related]
9. CASZ1 is a novel promoter of metastasis in ovarian cancer.
Wu YY; Chang CL; Chuang YJ; Wu JE; Tung CH; Chen YC; Chen YL; Hong TM; Hsu KF
Am J Cancer Res; 2016; 6(6):1253-70. PubMed ID: 27429842
[TBL] [Abstract][Full Text] [Related]
10. Targeting dual oncogenic machineries driven by TAL1 and PI3K-AKT pathways in T-cell acute lymphoblastic leukemia.
Lim FQ; Chan AS; Yokomori R; Huang XZ; Theardy MS; Yeoh AEJ; Tan SH; Sanda T
Haematologica; 2023 Feb; 108(2):367-381. PubMed ID: 36073513
[TBL] [Abstract][Full Text] [Related]
11. CASZ1: a promising factor modulating aldosterone biosynthesis and mineralocorticoid receptor activity.
Yokota K; Shibata H; Kurihara I; Itoh H; Sone M
Hypertens Res; 2023 Feb; 46(2):417-420. PubMed ID: 36522424
[TBL] [Abstract][Full Text] [Related]
12. CASZ1 promotes vascular assembly and morphogenesis through the direct regulation of an EGFL7/RhoA-mediated pathway.
Charpentier MS; Christine KS; Amin NM; Dorr KM; Kushner EJ; Bautch VL; Taylor JM; Conlon FL
Dev Cell; 2013 Apr; 25(2):132-43. PubMed ID: 23639441
[TBL] [Abstract][Full Text] [Related]
13. Targeting Wnt/β-catenin and PI3K/Akt/mTOR pathways in T-cell acute lymphoblastic leukemia.
Evangelisti C; Chiarini F; Cappellini A; Paganelli F; Fini M; Santi S; Martelli AM; Neri LM; Evangelisti C
J Cell Physiol; 2020 Jun; 235(6):5413-5428. PubMed ID: 31904116
[TBL] [Abstract][Full Text] [Related]
14. 20(S)-Ginsenoside Rh2 displays efficacy against T-cell acute lymphoblastic leukemia through the PI3K/Akt/mTOR signal pathway.
Xia T; Zhang J; Zhou C; Li Y; Duan W; Zhang B; Wang M; Fang J
J Ginseng Res; 2020 Sep; 44(5):725-737. PubMed ID: 32913402
[TBL] [Abstract][Full Text] [Related]
15. Acute leukemia cells resistant to PI3K/mTOR inhibition display upregulation of P2RY14 expression.
Shah K; Moharram SA; Kazi JU
Clin Epigenetics; 2018; 10():83. PubMed ID: 29951132
[TBL] [Abstract][Full Text] [Related]
16. Identification of CASZ1 NES reveals potential mechanisms for loss of CASZ1 tumor suppressor activity in neuroblastoma.
Liu Z; Lam N; Wang E; Virden RA; Pawel B; Attiyeh EF; Maris JM; Thiele CJ
Oncogene; 2017 Jan; 36(1):97-109. PubMed ID: 27270431
[TBL] [Abstract][Full Text] [Related]
17. Novel Ferrocene Derivatives Induce Apoptosis through Mitochondria-Dependent and Cell Cycle Arrest via PI3K/Akt/mTOR Signaling Pathway in T Cell Acute Lymphoblastic Leukemia.
Zeng L; Tang M; Pi C; Zheng J; Gao S; Chabanne T; Chauvin R; Cheng W; Lin H; Xu R; Cui X
Cancers (Basel); 2021 Sep; 13(18):. PubMed ID: 34572904
[TBL] [Abstract][Full Text] [Related]
18. Decitabine inhibits the proliferation of human T-cell acute lymphoblastic leukemia molt4 cells and promotes apoptosis partly by regulating the PI3K/AKT/mTOR pathway.
Zhang G; Gao X; Zhao X; Wu H; Yan M; Li Y; Zeng H; Ji Z; Guo X
Oncol Lett; 2021 May; 21(5):340. PubMed ID: 33747197
[TBL] [Abstract][Full Text] [Related]
19. The TAL1 complex targets the FBXW7 tumor suppressor by activating miR-223 in human T cell acute lymphoblastic leukemia.
Mansour MR; Sanda T; Lawton LN; Li X; Kreslavsky T; Novina CD; Brand M; Gutierrez A; Kelliher MA; Jamieson CH; von Boehmer H; Young RA; Look AT
J Exp Med; 2013 Jul; 210(8):1545-57. PubMed ID: 23857984
[TBL] [Abstract][Full Text] [Related]
20.
Jian H; Poetsch A
Biomedicines; 2023 Jul; 11(7):. PubMed ID: 37509718
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
